PE20030855A1 - Una dosis de sanorg 34006 para el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda - Google Patents
Una dosis de sanorg 34006 para el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profundaInfo
- Publication number
- PE20030855A1 PE20030855A1 PE2003000071A PE2003000071A PE20030855A1 PE 20030855 A1 PE20030855 A1 PE 20030855A1 PE 2003000071 A PE2003000071 A PE 2003000071A PE 2003000071 A PE2003000071 A PE 2003000071A PE 20030855 A1 PE20030855 A1 PE 20030855A1
- Authority
- PE
- Peru
- Prior art keywords
- sanorg
- patients
- dose
- treatment
- venous
- Prior art date
Links
- 206010051055 Deep vein thrombosis Diseases 0.000 title abstract 2
- 206010047249 Venous thrombosis Diseases 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000004043 venous thromboembolism Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
SE REFIERE A UNA DOSIS DE 2,5 mg DEL PENTASACARIDO METIL-O-(2,3,4-TRI-O-METIL-6-O-SULFO-O-D-GLUCOPIRANOSIL)-(1-4)-O-(ACIDO 2,3-DI-O-METIL-ß-D-GLUCOPIRANOSIL-URONICO)-(1-4)-O-(2,3,6-TRI-O-SULFO-O-D-GLUCOPIRANOSILO)-(1-4)-O-(ACIDO 2,3-DI-O-METIL-O-L-IDOPIRANOSIL URONICO)-(1-4)-2,3,6-TRI-O-SULFO-O-D-GLUCOPIRANOSIDO, SAL NANOSODICA (SANORG 34006) Y PUEDE SER UTIL PARA EL TRATAMIENTO O PROFILAXIS SECUNDARIA DE EVENTOS TROMBOTICOS VENOSOS EN PACIENTES CON TROMBOSIS VENOSA PROFUNDA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075374 | 2002-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030855A1 true PE20030855A1 (es) | 2003-10-11 |
Family
ID=27635850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000071A PE20030855A1 (es) | 2002-01-29 | 2003-01-23 | Una dosis de sanorg 34006 para el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7709463B2 (es) |
| EP (1) | EP1471924B1 (es) |
| JP (1) | JP4870907B2 (es) |
| CN (1) | CN1622813A (es) |
| AR (1) | AR038320A1 (es) |
| AT (1) | ATE323497T1 (es) |
| AU (1) | AU2003205664B2 (es) |
| BR (1) | BR0307196A (es) |
| CA (1) | CA2472957C (es) |
| CY (1) | CY1107661T1 (es) |
| DE (1) | DE60304678T2 (es) |
| DK (1) | DK1471924T3 (es) |
| EA (1) | EA007204B1 (es) |
| ES (1) | ES2262971T3 (es) |
| HK (1) | HK1072361A1 (es) |
| MX (1) | MXPA04007310A (es) |
| NO (1) | NO332699B1 (es) |
| PE (1) | PE20030855A1 (es) |
| PL (1) | PL207144B1 (es) |
| PT (1) | PT1471924E (es) |
| SI (1) | SI1471924T1 (es) |
| TW (1) | TWI281861B (es) |
| WO (1) | WO2003063881A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005312028A1 (en) * | 2004-12-01 | 2006-06-08 | Osi Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| WO2012166611A2 (en) | 2011-05-27 | 2012-12-06 | Immune Disease Institute, Inc. | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| WO2021007429A1 (en) | 2019-07-09 | 2021-01-14 | Optimvia Llc | Methods for synthesizing anticoagulant polysaccharides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en active IP Right Grant
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2005
- 2005-05-03 HK HK05103708A patent/HK1072361A1/xx not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI281861B (en) | 2007-06-01 |
| CY1107661T1 (el) | 2013-04-18 |
| US7709463B2 (en) | 2010-05-04 |
| WO2003063881A1 (en) | 2003-08-07 |
| ES2262971T3 (es) | 2006-12-01 |
| CN1622813A (zh) | 2005-06-01 |
| MXPA04007310A (es) | 2004-10-29 |
| CA2472957A1 (en) | 2003-08-07 |
| AR038320A1 (es) | 2005-01-12 |
| PL370557A1 (en) | 2005-05-30 |
| TW200302104A (en) | 2003-08-01 |
| BR0307196A (pt) | 2004-11-03 |
| HK1072361A1 (en) | 2005-08-26 |
| NO20043195L (no) | 2004-10-29 |
| CA2472957C (en) | 2011-09-13 |
| EP1471924B1 (en) | 2006-04-19 |
| DE60304678T2 (de) | 2007-04-05 |
| JP4870907B2 (ja) | 2012-02-08 |
| US20050209175A1 (en) | 2005-09-22 |
| EP1471924A1 (en) | 2004-11-03 |
| EA007204B1 (ru) | 2006-08-25 |
| NO332699B1 (no) | 2012-12-10 |
| DK1471924T3 (da) | 2006-08-21 |
| PT1471924E (pt) | 2006-09-29 |
| ATE323497T1 (de) | 2006-05-15 |
| AU2003205664B2 (en) | 2008-06-05 |
| DE60304678D1 (de) | 2006-05-24 |
| SI1471924T1 (sl) | 2006-10-31 |
| JP2005519919A (ja) | 2005-07-07 |
| PL207144B1 (pl) | 2010-11-30 |
| EA200400817A1 (ru) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wheeler et al. | The intrinsic pathway of coagulation as a target for antithrombotic therapy | |
| EE05419B1 (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| BRPI0515931A (pt) | compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos | |
| BRPI0513864A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades | |
| AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
| AR084285A1 (es) | Composiciones inmunogenicas | |
| MEP13008A (en) | C-aryl glucoside sglt2 inhibitors and method | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| PH12013502449A1 (en) | Novel method for preventing or treating m tuberculosis infection | |
| MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
| PE20060594A1 (es) | Composicion farmaceutica que contiene un agonista de ppar | |
| AR063470A1 (es) | Terapia combinada | |
| ECSP077387A (es) | Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio | |
| SE0950392L (sv) | Sammansättning för behandling av hudåkommor | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
| BRPI0509667A (pt) | azaquinazolinas substituìdas com eficácia antiviral | |
| EA200200502A1 (ru) | Способ введения ингибитора фосфодиэстеразы 4 | |
| BR0314261A (pt) | Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento | |
| PE20030855A1 (es) | Una dosis de sanorg 34006 para el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda | |
| BR0313278A (pt) | Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo e sua utilização, método para o tratamento e profilaxia de enfermidades e obesidade e utilização dos compostos | |
| SE0004101D0 (sv) | New use | |
| GT200500315A (es) | Formas de dosificacion oral solidas que contienen una dosis baja de estradiol | |
| ES2088877T3 (es) | Procedimiento de preparacion del 3-pirrolidinol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |